tradingkey.logo

Immuneering rises after smaller-than-expected Q3 loss

ReutersNov 13, 2025 3:27 PM

Shares of therapy developer Immuneering Corp.IMRX.O rise 7% to $7.08

Company posts Q3 net loss of 38 cents per share compared to analysts' estimated loss of 39 cents per share

Cash, and cash equivalents as of September 30 were $227.6 million, compared with $36.1 million as of December 31, 2024

Including session's moves, stock has more than tripled YTD

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey

Related Articles

Tradingkey
KeyAI